PB
UTHR icon

Pinnacle Bancorp’s United Therapeutics UTHR Stock Holding History

Pinnacle Bancorp’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6
Closed -$1K – 763
2022
Q3 		$1K Hold
6
– – ﹤0.01% 733
2022
Q2 		$1K Hold
6
– – ﹤0.01% 748
2022
Q1 		$1K Buy
+6
New +$1.14K ﹤0.01% 742

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Bancorp's UTHR Position: Q4 2022 in Review

Pinnacle Bancorp sold out of United Therapeutics (UTHR) in Q4 2022, closing a stake of 6 shares — an estimated $1K sold.

Pinnacle Bancorp first reported a position in UTHR in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 511 funds tracked by Wall St. Rank hold UTHR as of Q4 2022.

  • Pinnacle Bancorp reported no remaining United Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Pinnacle Bancorp sold 6 United Therapeutics shares in Q4 2022, an estimated $1K.
  • Pinnacle Bancorp first reported a position in United Therapeutics in Q1 2022 and held it in 3 quarters.
  • Pinnacle Bancorp's United Therapeutics position peaked at $1K in Q3 2022.
  • 511 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2022.

Based on Pinnacle Bancorp's 13F filing for Q4 2022, filed 24 Jan 2023.